KRAS and familial pancreatic carcinoma: In addition, 50% of RAP patients have gene mutations (such as repeated inflammatory stimulation that can lead to Kras gene mutations)25, which will increase the risk of chronic pancreatitis and pancreatic cancer and seriously affect the quality of patient's life26.